aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · IEX Real-Time Price · USD
1.650
-0.120 (-6.78%)
Jun 18, 2024, 4:00 PM EDT - Market closed

aTyr Pharma Revenue

aTyr Pharma had revenue of $588.00K in the twelve months ending March 31, 2024, down -94.34% year-over-year. Revenue in the quarter ending March 31, 2024 was $235.00K. In the year 2023, aTyr Pharma had annual revenue of $353.00K, a decrease of -96.60%.

Revenue (ttm)
$588.00K
Revenue Growth
-94.34%
P/S Ratio
193.65
Revenue / Employee
$10,500
Employees
56
Market Cap
113.87M

Revenue Chart

* The company reports in USD currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023353.00K-10.03M-96.60%
Dec 31, 202210.39M--
Dec 31, 20210--
Dec 31, 202010.46M10.03M2,377.49%
Dec 31, 2019422.00K--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Karyopharm Therapeutics 140.46M
Seres Therapeutics 126.85M
Electromed 53.50M
Adagene 18.11M
Veru Inc. 13.48M
Revenue Rankings